Blue Edge Capital’s Amgen AMGN Stock Holding History

Blue Edge Capital’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$722K	Hold	1,714	–	–	0.09%	87
2026 Q2	$621K	Sell	1,714 -400	-19%	-$137K	0.07%	93
2026 Q1	$744K	Buy	2,114 +4	+0.2%	+$1.43K	0.1%	87
2025 Q4	$691K	Buy	2,110 +377	+22%	+$120K	0.09%	88
2025 Q3	$489K	Hold	1,733	–	–	0.07%	94
2025 Q2	$484K	Hold	1,733	–	–	0.07%	91
2025 Q1	$540K	Hold	1,733	–	–	0.09%	86
2024 Q4	$452K	Hold	1,733	–	–	0.07%	91
2024 Q3	$558K	Hold	1,733	–	–	0.09%	85
2024 Q2	$541K	Hold	1,733	–	–	0.09%	86
2024 Q1	$493K	Hold	1,733	–	–	0.08%	90
2023 Q4	$499K	Buy	1,733 +400	+30%	+$109K	0.09%	83
2023 Q3	$358K	Hold	1,333	–	–	0.08%	90
2023 Q2	$296K	Hold	1,333	–	–	0.06%	91
2023 Q1	$322K	Hold	1,333	–	–	0.07%	92
2022 Q4	$350K	Hold	1,333	–	–	0.08%	94
2022 Q3	$300K	Hold	1,333	–	–	0.07%	92
2022 Q2	$324K	Hold	1,333	–	–	0.08%	91
2022 Q1	$322K	Hold	1,333	–	–	0.06%	95
2021 Q4	$300K	Hold	1,333	–	–	0.06%	92
2021 Q3	$283K	Hold	1,333	–	–	0.06%	89
2021 Q2	$325K	Hold	1,333	–	–	0.07%	94
2021 Q1	$332K	Hold	1,333	–	–	0.07%	85
2020 Q4	$306K	Hold	1,333	–	–	0.07%	89
2020 Q3	$339K	Hold	1,333	–	–	0.09%	81
2020 Q2	$314K	Hold	1,333	–	–	0.09%	81
2020 Q1	$270K	Buy	+1,333	New	+$291K	0.1%	85

Other funds holding AMGN

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Capital World Investors Los Angeles, California $824B AUM 37.44% 1-Year Est. Return

Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $704B AUM 26.74% 1-Year Est. Return

Primecap Management Pasadena, California $161B AUM 86.05% 1-Year Est. Return

Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Blue Edge Capital's AMGN Position: Q3 2026 in Review

Blue Edge Capital held its Amgen (AMGN) position steady in Q3 2026 at 1,714 shares worth $722K. The position accounts for 0.09% of the portfolio, ranked #87.

Blue Edge Capital first reported a position in AMGN in Q1 2020 and has held it in 27 quarters since. The position peaked at $744K in Q1 2026. 2,617 funds tracked by Wall St. Rank hold AMGN as of Q3 2026.

Blue Edge Capital held 1,714 shares of Amgen worth $722K as of Q3 2026.
Blue Edge Capital left its Amgen share count unchanged in Q3 2026.
Amgen made up 0.09% of Blue Edge Capital's portfolio in Q3 2026, its #87 holding.
Blue Edge Capital first reported a position in Amgen in Q1 2020 and has held it in 27 quarters since.
Blue Edge Capital's Amgen position peaked at $744K in Q1 2026.
2,617 funds tracked by Wall St. Rank held Amgen as of Q3 2026.

Based on Blue Edge Capital's 13F filing for Q3 2026, filed 12 Nov 2026.